Eli Lilly Gets CDSCO Panel Nod for Ixekizumab Safety Label Update Dr. Divya Colin9 Aug 2025 12:30 PM ISTNew Delhi: Eli Lilly and Company (India) Pvt Ltd has secured regulatory clearance from the Subject Expert Committee (SEC) under the Central Drugs...
Severe Skin Reactions Linked to 15-Fold Higher Risk of Autoimmune Diseases: Study Medha Baranwal6 Aug 2025 8:15 PM ISTTaiwan: Patients who experience severe cutaneous adverse reactions (SCARs) could face a markedly higher risk of developing autoimmune diseases (ADs),...
Deucravacitinib Relieves Skin and Joint Symptoms in Psoriasis and Psoriatic Arthritis: Study Dr Riya Dave31 July 2025 8:45 PM ISTResearchers have found in a new research that deucravacitinib significantly improves joint pain and musculoskeletal symptoms in patients with...
Topical Omega-3 PUFAs Show Promise for Skin Conditions Like Psoriasis and Dermatitis: Study Jacinthlyn Sylvia29 July 2025 9:00 PM ISTA new study published in the Journal of Cosmetic Dermatology revealed that dermatologic benefits of topical omega-3 polyunsaturated fatty acids...
Smoking Significantly Increases Psoriasis Relapse Risk, reveals research Dr Riya Dave25 July 2025 8:45 AM ISTResearchers have established that smoking tobacco has a high likelihood of increasing the risk of relapse in patients receiving treatment for...
Psoriasis May Offer Protection Against Certain Cancers, Study Suggests Medha Baranwal21 July 2025 9:30 PM ISTChina: A recent Mendelian randomization (MR) study has revealed that psoriasis may be inversely associated with uterine corpus cancer in women and...
Air Pollution Linked to Higher Psoriasis Risk Through Accelerated Biological Aging: Study Medha Baranwal14 July 2025 8:30 PM ISTChina: Prolonged exposure to air pollutants may significantly raise the risk of developing psoriasis, with accelerated biological aging acting as a...
Guselkumab Effective and Long-Lasting Psoriasis Treatment Across All Skin Tones, suggests study Jacinthlyn Sylvia9 July 2025 8:30 PM ISTA new study published in the Journal of American Medical Association showed that Guselkumab was highly effective and durable treatment for psoriasis,...
Roflumilast Foam as a Promising Topical Treatment for Scalp and Body Psoriasis: Phase 3 ARRECTOR Trial Medha Baranwal7 July 2025 8:30 PM ISTCanada: In a major development for topical psoriasis therapy, researchers have found that roflumilast foam, 0.3%, applied once daily, significantly...
Sleep and Testosterone: Dual Drivers of Psoriasis Risk in Men: Study Dr. Shravani Dali3 July 2025 8:15 PM ISTMen with low testosterone levels below 300 ng/dL are twice as likely to develop psoriasis (OR 2.97), while sleep less than 7 hours was associated with...
Icotrokinra Shows High Efficacy and Safety in Treating Adolescent Psoriasis: Study Dr. Kamal Kant Kohli25 Jun 2025 8:15 PM ISTA new subgroup analysis reveals that adolescents with moderate-to-severe plaque psoriasis treated with once-daily icotrokinra (JNJ-2113) achieved...
Dupilumab used for atopic dermatitis Linked to Increased Risk of Psoriasis: JAMA Jacinthlyn Sylvia23 Jun 2025 8:30 PM ISTA new study published in the Journal of American Medical Association showed that dupilumab (Dupixent), used for treating atopic dermatitis, is...
